These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver]. Serov NA, Sukhanov VA, Podymova SD. Klin Med (Mosk); 1991 Apr; 69(4):73-5. PubMed ID: 1865658 [Abstract] [Full Text] [Related]
12. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease. Van Thiel DH, George M, Fareed J. Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503 [Abstract] [Full Text] [Related]
13. Coagulation and fibrinolysis in individuals with advanced liver disease. Van Thiel DH, George M, Mindikoğlu AL, Baluch MH, Dhillon S. Turk J Gastroenterol; 2004 Jun; 15(2):67-72. PubMed ID: 15334312 [Abstract] [Full Text] [Related]
14. [Anomalies of hemostasis in hepatopathies]. Oliver JM, Gruel Y, Bacq Y. Gastroenterol Clin Biol; 1991 Jun; 15(10):679-88. PubMed ID: 1816008 [No Abstract] [Full Text] [Related]
17. [Hemostatic changes in the course of different chronic hepatopathies]. Ruggiero G, De Biasi R, Lembo N, Giusti G. Minerva Med; 1975 Feb 21; 66(13):595-601. PubMed ID: 1113909 [Abstract] [Full Text] [Related]